Abex Group partnered with a deep-tech healthcare startup in Singapore that developed an AI-powered diagnostic platform for the early detection of cardiovascular diseases. Although the algorithm demonstrated exceptional accuracy in clinical trials, the company faced significant challenges with clinical deployment, regulatory approval, and integration into hospital systems across Asia. To address these hurdles, we provided strategic funding and regulatory guidance, supporting compliance with Singapore’s Health Sciences Authority (HSA) and preparation for CE and FDA submissions. Leveraging our regional health innovation network, we also facilitated hospital partnerships and enabled seamless integration with existing health record and imaging systems. Today, the platform is deployed in select hospitals across Singapore and has secured regional funding to expand clinical validation studies, setting the stage for broader adoption across Asia.